Regulatory volume decrease (RVD) is a key mechanism for volume control that serves to prevent detrimental swelling in response to hypo-osmotic stress. The molecular basis of RVD is not understood. Here we show that a complex containing aquaporin-4 (AQP4) and transient receptor potential vanilloid 4 (TRPV4) is essential for RVD in astrocytes. Astrocytes from AQP4-KO mice and astrocytes treated with TRPV4 siRNA fail to respond to hypotonic stress by increased intracellular Ca 2+ and RVD. Coimmunoprecipitation and immunohistochemistry analyses show that AQP4 and TRPV4 interact and colocalize. Functional analysis of an astrocyte-derived cell line expressing TRPV4 but not AQP4 shows that RVD and intracellular Ca 2+ response can be reconstituted by transfection with AQP4 but not with aquaporin-1. Our data indicate that astrocytes contain a TRPV4/AQP4 complex that constitutes a key element in the brain's volume homeostasis by acting as an osmosensor that couples osmotic stress to downstream signaling cascades.water channel | glia | brain edema A basic property of any cell type is the ability to resist volume changes in the face of hypotonic stress. Thus, most cells are equipped with mechanisms that help bring cell volume back toward baseline level in the wake of an osmotically induced swelling response. This volume recovery, termed "regulatory volume decrease" (RVD) (1), plays a critical role in the brain, whose functional and structural integrity depends on finely tuned volume homeostasis at the cellular as well as the organ level.A wealth of data indicates that astroglial cells are essential for the maintenance of volume homeostasis in brain (2). Being equipped with AQP4 water channels in their foot processes at the interface between brain and liquid spaces, astrocytes are the first cells to be exposed to osmotic changes and the first cells to swell in response to hypo-osmotic stress (3-5). Further, the proximity of the astroglial processes to the subarachnoidal space and vessels (which act as sinks for excess osmolytes) places astroglia in a unique position for mediating regulatory volume changes, on the part of the astrocytic syncytium and the brain as a whole.A full mechanistic understanding of RVD would pave the way for more sophisticated measures to curtail pathological changes in brain water transport and distribution, as seen in brain tumors, stroke, and several other acute conditions that carry a high morbidity and lethality because of the loss of volume homeostasis. Future drugs affecting AQP4-mediated water transport would be expected to alleviate the acute consequences of inadvertent changes in osmotic driving forces. However, because the lipid bilayer of plasma membranes allows water diffusion (albeit to a restricted extent compared with membranes containing aquaporins), the long-term consequences of osmotic challenges can be offset only by manipulating the osmotic gradients per se. In this context, the RVD mechanisms stand out as targets of potential pharmacological interest (1, 6).Previous studies of t...